INS and metabolic dysfunction-associated steatotic liver disease: The authors propose that individuals with well-controlled T1D may maintain normal hepatic glycogen stores and preserve a physiological glucagon-to-insulin ratio, which could protect against both insulin resistance and MASLD development [21].